A phase II trial of valproic acid in patients with advanced, radioiodineaeresistant thyroid cancers of follicular cell origin

From WikiCitingRetracted
Revision as of 03:14, 12 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == A phase II trial of valproic acid in patients with advanced, radioiodineaeresistant thyroid cancers of follicular cell origin; N Nilubol, Merkel, L Yang, D Patelae; 2017; doi_citing_unknown == Retraction == Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy ; Yoshihiro Sato Izumi Kondo S Ishida H Motooka K Takayama Y Tomita H Maeda Kei Satoh; 08/14/2001 ; https://doi.org/10.?1212/?WNL.?57.?3.?445...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Target Article[edit | edit source]

A phase II trial of valproic acid in patients with advanced, radioiodineaeresistant thyroid cancers of follicular cell origin; N Nilubol, Merkel, L Yang, D Patelae; 2017; doi_citing_unknown

Retraction[edit | edit source]

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy  ; Yoshihiro Sato Izumi Kondo S Ishida H Motooka K Takayama Y Tomita H Maeda Kei Satoh; 08/14/2001

https://doi.org/10.?1212/?WNL.?57.?3.?445

Citation piece[edit | edit source]

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=A_phase_II_trial_of_valproic_acid_in_patients_with_advanced,_radioiodineaeresistant_thyroid_cancers_of_follicular_cell_origin&oldid=10265"